60943-39-7

Basic information

• Product Name: Ethyl 2-Methoxy-a,g-dioxo-benzenebutanoate
• Synonyms: Ethyl 2-Methoxy-a,g-dioxo-benzenebutanoate
• CAS NO: 60943-39-7
• Molecular Formula: C₁₃H₁₄O₅
• Molecular Weight: 250.24726
• Mol File: 60943-39-7.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Ethyl 2-Methoxy-a,g-dioxo-benzenebutanoate(CAS DataBase Reference)
• NIST Chemistry Reference: Ethyl 2-Methoxy-a,g-dioxo-benzenebutanoate(60943-39-7)
• EPA Substance Registry System: Ethyl 2-Methoxy-a,g-dioxo-benzenebutanoate(60943-39-7)

Safety Data

• Hazardous Substances Data: 60943-39-7(Hazardous Substances Data)

Upstream product

• 118-93-4 o-hydroxyacetophenone 
• 579-74-8 2-Methoxyacetophenone 
• 95-92-1 oxalic acid diethyl ester 

Downstream Products

• 110578-38-6 2-amino-4-oxo-4-o-methoxyphenyl-2-butenoic acid ethyl ester 
• 110578-42-2 5-o-methoxyphenyl-3(2H)-furanone 
• 110578-34-2 2-buten-1-one-3-amino-4-hydroxy-1-o-methoxyphenyl 
• 110578-35-3 2-penten-1-one-3-amino-4-hydroxy-4-methyl-1-o-methoxyphenyl 
• 939053-53-9 ethyl 5-(2-methoxyphenyl)-1H-pyrazole-3-carboxylate 
• 110578-28-4 ethyl 5-(2-methoxyphenyl)isoxazole-3-carboxylate 

Relevant articles and documents

Rational modification, synthesis and biological evaluation of 3,4-dihydroquinoxalin-2(1H)-one derivatives as potent and selective c-Jun N-terminal kinase 3 (JNK3) inhibitors

The c-Jun N-terminal kinase 3 (JNK3) plays key roles in a wide range of diseases, including neurodegeneration diseases, inflammation diseases, cancers, cardiovascular diseases, and metabolic disorders. Previously, we have identified a lead compound, (Z)-3

PYRAZOLE DERIVATIVES AS S1P1 AGONISTS

The present invention relates to a compound of formula (I), to the process for preparing such compounds and to their use in the treatment of a pathological condition or disease susceptible to amelioration by sphingosine-1-phosphate receptors (S1P1) agonists.

GLUCOKINASE ACTIVATORS

Compounds, pharmaceutical compositions, kits and methods are provided for use with glucokinase that comprise a compound selected from the group consisting of: wherein the variables are as defined herein.